- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$198.38
7D
-0.3%
1Y
35.6%
BioNTech
Market Cap: US$21.7b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$94.86
7D
13.1%
1Y
-4.1%
Illumina
Market Cap: US$18.2b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$120.84
7D
-1.2%
1Y
41.9%
Elanco Animal Health
Market Cap: US$11.6b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.18
7D
6.4%
1Y
132.9%
Sam Chun Dang Pharm
Market Cap: ₩17.2t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩784,000.00
7D
1.3%
1Y
334.3%
Regencell Bioscience Holdings
Market Cap: US$11.2b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$22.97
7D
-6.3%
1Y
2,662.2%